Publication: Nesfatin–1 as a Novel Appetite-Controlling Peptide: Will Obesity Be History?
| dc.authorscopusid | 8279592000 | |
| dc.authorscopusid | 15847900800 | |
| dc.authorscopusid | 6505859458 | |
| dc.authorscopusid | 8279591800 | |
| dc.contributor.author | Baydin, A. | |
| dc.contributor.author | Erenler, A.K. | |
| dc.contributor.author | Atmaca, H. | |
| dc.contributor.author | Yardan, T. | |
| dc.date.accessioned | 2020-06-21T13:46:15Z | |
| dc.date.available | 2020-06-21T13:46:15Z | |
| dc.date.issued | 2015 | |
| dc.department | Ondokuz Mayıs Üniversitesi | en_US |
| dc.department-temp | [Baydin] Ahmet, Department of Emergency Medicine, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Erenler] Ali Kemal, Department of Emergency Medicine, Corum State Hospital, Corum, Corum, Turkey; [Atmaca] Hulusi M., Department of Emergency Medicine, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Yardan] Türker, Department of Emergency Medicine, Ondokuz Mayis Üniversitesi, Samsun, Turkey | en_US |
| dc.description.abstract | In this study, we aimed to determine the role of a novel peptide – nesfatin 1- in appetite control and defne its anorectic mechanism in order to reveal whether it can be used in fght against obesity. We reviewed the articles in the literature investigating the structure, mechanism of effect and experimental usefulness of nesfatin-1. We entered the word “nesfatin” to medical databases and reviewed the literature. Administration of nesfatin-1 maintains a signifcant reduce in food intake. Its effectiveness in rats is proven. More and more, new researches are in progress to determine its exact mechanism of effect. Nesfatin-1 is a satiety agent. However, use of nesfatin-1 as an anti-obesity agent in humans remains an unclarifed feld and needs further investigations. © 2015 Galenos Yayincilik, All rights reserved. | en_US |
| dc.identifier.doi | 10.4274/tjem.2297 | |
| dc.identifier.endpage | 64 | en_US |
| dc.identifier.issn | 1301-2193 | |
| dc.identifier.issn | 1308-9846 | |
| dc.identifier.issue | 2 | en_US |
| dc.identifier.scopus | 2-s2.0-84932167690 | |
| dc.identifier.scopusquality | Q4 | |
| dc.identifier.startpage | 60 | en_US |
| dc.identifier.uri | https://doi.org/10.4274/tjem.2297 | |
| dc.identifier.volume | 19 | en_US |
| dc.identifier.wos | WOS:000362601500007 | |
| dc.language.iso | en | en_US |
| dc.publisher | Turkiye Klinikleri | en_US |
| dc.relation.ispartof | Turkish Journal of Endocrinology and Metabolism | en_US |
| dc.relation.journal | Turkish Journal of Endocrinology and Metabolism | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Endocrine Effects | en_US |
| dc.subject | Nesfatin–1 | en_US |
| dc.subject | Obesity | en_US |
| dc.subject | Sympathetic Activity | en_US |
| dc.title | Nesfatin–1 as a Novel Appetite-Controlling Peptide: Will Obesity Be History? | en_US |
| dc.title.alternative | İştah Kontrolünde Yeni Bir Peptid Olarak Nesfatin–1: Obezite Tarih Mi Olacak | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication |
